Clinical Trial Detail

Clinical Trials

Clinical Trial Detail

Optimizing Cord Blood and Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (CHAMP)

Complete title: Optimizing Haploidentical Aplastic Anemia Transplantation (CHAMP)

Research Study Number 9818
 
Principal Investigator Kanwaldeep Mallhi
 
Phase II

Research Study Description

This study is a prospective, simultaneous, parallel phase II study with one arm receiving unrelated cord blood transplantation and the other arm receiving haploidentical transplantation for Severe Aplastic Anemia (SAA) patients. The primary objective is to assess overall survival (OS) separately in the 2 arms at 1 year post-hematopoietic stem cell transplantation (HSCT).

Eligibility Criteria (must meet the following to participate in this study)

** For Eligibility information, please click on the "Look up trial at NIH" link above. **

Other eligibility criteria may apply.

Research Study Number 9818
 
Contact Seattle Cancer Care Alliance Intake Office
 
Telephone 800-804-8824 / 206-606-1024
 

Keywords: Anemia, Aplastic; Hematologic Malignancies; Pediatric Cancers, Miscellaneous; Anemia; Bone Marrow Diseases; Anemia, Severe Aplastic (SAA)

Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.

Please remember:

  • Talk to your health care providers first before making decisions about your health care.
  • Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each study.

Subscribe to an RSS feed of all trials